4 Ways To Tell if You’re Actually Buying a Quality Supplement
Fact checked by Nick Blackmer Supplements don’t need FDA approval before they hit shelves.Credit: d3sign / Getty Images…
Nearly 90,000 bottles of children’s liquid pain medication recalled
WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
Nearly 90,000 bottles of children’s liquid pain medication recalled
WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
Coming Soon: ‘Wegovy HD’
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
FDA issues CRL to Aldeyra’s reproxalap drug application
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Aldeyra Therapeutics for…
Mothers ‘Terrified’ as Children Could Lose Treatments After FDA Denials
Mothers from across the country have spoken to Newsweek about their concern for their children after the Food…
Multivitamin Recall Update for 25 States As FDA Sets Risk Level
A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended…
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug…
Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval
March 2 (Reuters) – Eli Lilly CFO Lucas Montarce said on Monday it is preparing to launch its…
FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressants
WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…